Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Aug;75(4):352-61.
doi: 10.1002/msj.20055.

Past, present, and future of insulin pump therapy: better shot at diabetes control

Affiliations
Review

Past, present, and future of insulin pump therapy: better shot at diabetes control

Jennifer Sherr et al. Mt Sinai J Med. 2008 Aug.

Abstract

With the advent of continuous subcutaneous insulin infusion therapy and the findings of the Diabetes Control and Complications Trial, the management of type 1 diabetes has changed drastically. Over the past 30 years since its development, the effectiveness of continuous subcutaneous insulin infusion has been assessed in comparison with other modes of intensive treatment. Additionally, improvements in pump delivery systems have been made. Here, the findings of the studies on pump therapy are reviewed. Selection criteria of patients for pump use and how to initiate pump therapy are presented. Finally, newer findings on continuous glucose sensors are discussed as the next era of pump therapy continues to focus on the goal of developing an artificial pancreas.

PubMed Disclaimer

References

    1. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573–578. - PubMed
    1. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J. 1978;1:204–207. - PMC - PubMed
    1. Home PD, Pickup JC, Keen H, Alberti KG, Parsons JA, Binder C. Continuous Subcutaneous Insulin Infusion: Comparison of Plasma Insulin Profiles After Infusion or Bolus Injection of the Mealtime Dose. Metabolism. 1981;30:439–442. - PubMed
    1. Lauritezen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of Continuous Subcutaneous Insulin Infusion. Diabetologia. 1983;24:326–329. - PubMed
    1. Amiel SA, Tamborlane WV, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med. 1987;316:1376–1383. - PubMed

Publication types

MeSH terms